SCHEMBL912960

SCHEMBL912960

COc1ccc(CNC(=O)OCCOc2cc(N3CCOCC3)nc(NN=Cc3cccc(C)c3)n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIKFYVE Q9Y2I7 10/20 0.48
FES P07332 1/20 0.48
FER P16591 1/20 0.48
TYK2 P29597 1/20 0.48
FRK P42685 1/20 0.48
SYK P43405 1/20 0.48
CAMK1D Q8IU85 1/20 0.48
IRAK4 Q9NWZ3 1/20 0.48
MAPT P10636 4/20 0.46
KDM4E B2RXH2 3/20 0.46
LMNA P02545 3/20 0.46
HPGD P15428 1/20 0.46
KMT2A Q03164 1/20 0.42
ALDH1A1 P00352 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
POLB P06746 1/20 0.40
ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL912959 1.00 PIKFYVE (0.48) PIKFYVEFESFERTYK2FRK
SCHEMBL12903017 0.88 PIKFYVE (0.63) PIKFYVEFESFERTYK2FRK
SCHEMBL913585 0.87 PIKFYVE (0.51) PIKFYVEFESFERTYK2FRK
SCHEMBL913583 0.87 PIKFYVE (0.51) PIKFYVEFESFERTYK2FRK
SCHEMBL912404 0.84 PIKFYVE (0.54) PIKFYVEFESFERTYK2FRK
SCHEMBL912405 0.84 PIKFYVE (0.54) PIKFYVEFESFERTYK2FRK
SCHEMBL913150 0.83 PIKFYVE (0.53) PIKFYVEFESFERTYK2FRK
SCHEMBL913152 0.83 PIKFYVE (0.53) PIKFYVEFESFERTYK2FRK
SCHEMBL12903016 0.75 PIKFYVE (0.68) PIKFYVEFESFERTYK2FRK
SCHEMBL427744 0.74 PIKFYVE (0.51) PIKFYVEFESFERTYK2FRK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7872005-B2 2-substituted heteroaryl compounds SYNTA PHARMACEUTICALS CORPORATION (US) 2011-01-18 US claimed
US-20060063739-A1 2-Substituted heteroaryl compounds LSI FINANCING LLC, AS ADMINISTRATIVE AGENT 2006-03-23 US claimed
US-7872005-B2 2-substituted heteroaryl compounds SYNTA PHARMACEUTICALS CORPORATION (US) 2011-01-18 US disclosed
US-20060063739-A1 2-Substituted heteroaryl compounds LSI FINANCING LLC, AS ADMINISTRATIVE AGENT 2006-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063739-A1 2-Substituted heteroaryl compounds IL2, IL4, IL2RA PIKFYVE 4258/4885FES 2427/4885FER 3322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.